StockWatch
·

Eris Lifesciences Ltd Q1 FY26 Results

ERISQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue773.009.6%
Total Income775.698.8%
Expenditure615.485.3%
PBT160.2124.4%
Net Profit125.1022.2%
OPM35.80%0.02pp
NPM16.13%1.78pp
EPS8.6625.5%
View full financials

Informational and educational content only. Not investment advice.